Zdrowie i gospodarka · 28.09.1994
Biologics; Technical Amendment
The Food and Drug Administration (FDA) is amending the biologics regulations by substituting the term ``supplement'' for ``amendment'' when referring to the submission of a change to an approved establishment license or product license application. This action is being taken to harmonize the regulations with terminology used in the Prescription Drug User Fee Act of 1992.